Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to confirm the safety profile such as the frequency of serious adverse events or any unexpected adverse events and overall efficacy of Faslodex for long term treatment in daily clinical practice.
MC MD
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Faslodex |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of adverse drug reactions. | 1 year | |
| Incidence of serious adverse events. | 1 Year |
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of adverse drug reactions with injection site reaction, thromboembolic events and hepatic impairment | 1 year | |
| Progression-free survival | 6 month | |
| Progression-free survival |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patients treated with Faslodex for the first time due to postmenopausal breast cancer
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Shigeru Yoshida | AstraZeneca KK | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research Site | Aichi | Japan | ||||
| Research Site |
Not provided
| Label | URL |
|---|---|
| CSR\_Synopsis\_D6997C00008 | View source |
| D6997C00008Fulvestrant\_Specific\_Clinical\_Experience\_Investigation\_Protocol\_redacted\_23February2016 | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
| 1 year |
| Akita |
| Japan |
| Research Site | Aomori | Japan |
| Research Site | Chiba | Japan |
| Research Site | Fukui | Japan |
| Research Site | Fukuoka | Japan |
| Research Site | Fukushima | Japan |
| Research Site | Gifu | Japan |
| Research Site | Gunma | Japan |
| Research Site | Hiroshima | Japan |
| Research Site | Hokkaido | Japan |
| Research Site | Hyōgo | Japan |
| Research Site | Ibaraki | Japan |
| Research Site | Ishikawa | Japan |
| Research Site | Kagawa | Japan |
| Research Site | Kagoshima | Japan |
| Research Site | Kanagawa | Japan |
| Research Site | Kochi | Japan |
| Research Site | Kumamoto | Japan |
| Research Site | Kyoto | Japan |
| Research Site | Miyagi | Japan |
| Research Site | Miyazaki | Japan |
| Research Site | Nagano | Japan |
| Research Site | Nagasaki | Japan |
| Research Site | Nara | Japan |
| Research Site | Niigata | Japan |
| Research Site | Okayama | Japan |
| Research Site | Okinawa | Japan |
| Research Site | Osaka | Japan |
| Research Site | Ōita | Japan |
| Research Site | Saga | Japan |
| Research Site | Saitama | Japan |
| Research Site | Shiga | Japan |
| Research Site | Shizuoka | Japan |
| Research Site | Tochigi | Japan |
| Research Site | Tokushima | Japan |
| Research Site | Tokyo | Japan |
| Research Site | Tottori | Japan |
| Research Site | Toyama | Japan |
| Research Site | Wakayama | Japan |
| Research Site | Yamagata | Japan |
| Research Site | Yamaguchi | Japan |
| Research Site | Yamanashi | Japan |
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
Not provided
Not provided